[go: up one dir, main page]

NO983100D0 - 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity - Google Patents

4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity

Info

Publication number
NO983100D0
NO983100D0 NO983100A NO983100A NO983100D0 NO 983100 D0 NO983100 D0 NO 983100D0 NO 983100 A NO983100 A NO 983100A NO 983100 A NO983100 A NO 983100A NO 983100 D0 NO983100 D0 NO 983100D0
Authority
NO
Norway
Prior art keywords
cisoxazoles
dihydronaphth
derivatives
cns activity
cns
Prior art date
Application number
NO983100A
Other languages
Norwegian (no)
Other versions
NO983100L (en
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO983100D0 publication Critical patent/NO983100D0/en
Publication of NO983100L publication Critical patent/NO983100L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO983100A 1996-01-05 1998-07-03 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity NO983100L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05
PCT/US1996/019569 WO1997025317A1 (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Publications (2)

Publication Number Publication Date
NO983100D0 true NO983100D0 (en) 1998-07-03
NO983100L NO983100L (en) 1998-09-04

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983100A NO983100L (en) 1996-01-05 1998-07-03 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity

Country Status (14)

Country Link
EP (1) EP0874833A1 (en)
JP (1) JP3161737B2 (en)
KR (1) KR100308748B1 (en)
CN (1) CN1214046A (en)
AR (1) AR005347A1 (en)
AU (1) AU710059B2 (en)
BR (1) BR9612578A (en)
CA (1) CA2241845C (en)
HU (1) HUP9903706A3 (en)
IL (1) IL125197A0 (en)
NO (1) NO983100L (en)
NZ (1) NZ325587A (en)
WO (1) WO1997025317A1 (en)
ZA (1) ZA9725B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8656101A (en) * 2000-08-21 2002-03-04 Univ Georgetown 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
KR20040093061A (en) * 2002-04-02 2004-11-04 얀센 파마슈티카 엔.브이. Substituted amino isoxazoline derivatives and their use as anti-depressants
TW200409777A (en) * 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
ATE456568T1 (en) 2002-08-15 2010-02-15 Janssen Pharmaceutica Nv CONDENSED HETEROCYCLIC ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTIDEPRESSANTS
AU2003271567B2 (en) * 2002-08-21 2009-12-24 Janssen Pharmaceutica N.V. C6- and C9-substituted chromeno (4, 3-C) isoxazoline derivatives and their use as anti-depressants
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
KR20130036171A (en) 2009-10-29 2013-04-11 브리스톨-마이어스 스큅 컴퍼니 Tricyclic heterocyclic compounds
ES2859478T3 (en) 2016-09-02 2021-10-04 Bristol Myers Squibb Co Substituted tricyclic heterocyclic compounds
WO2019032632A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company Alkylphenyl compounds
WO2019032631A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company OXIME ETHER COMPOUNDS
KR102002633B1 (en) 2018-07-19 2019-07-22 김태효 Non slip foot wear with separating cushion part

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
DK0402644T3 (en) * 1989-05-19 1996-01-02 Hoechst Roussel Pharma N- (Aryloxyalkyl) heteroaryl piperidines and heteroaryl piperazines, process for their preparation and their use as medicaments
JPH08502958A (en) * 1992-10-23 1996-04-02 メルク シヤープ エンド ドーム リミテツド Dopamine receptor subtype ligand

Also Published As

Publication number Publication date
AR005347A1 (en) 1999-04-28
EP0874833A1 (en) 1998-11-04
ZA9725B (en) 1997-07-07
AU710059B2 (en) 1999-09-09
AU1412697A (en) 1997-08-01
CN1214046A (en) 1999-04-14
JPH11510816A (en) 1999-09-21
IL125197A0 (en) 1999-03-12
CA2241845A1 (en) 1997-07-17
HUP9903706A2 (en) 2000-08-28
JP3161737B2 (en) 2001-04-25
BR9612578A (en) 1999-07-27
KR19990077033A (en) 1999-10-25
CA2241845C (en) 2002-10-01
HUP9903706A3 (en) 2000-09-28
KR100308748B1 (en) 2001-12-12
NZ325587A (en) 1999-02-25
NO983100L (en) 1998-09-04
WO1997025317A1 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
DK1454907T3 (en) Quninazoline and pyridopyrmidine derivatives
IS4970A (en) Determines 6,6-hetero-bicyclic derivatives
NO961425D0 (en) 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
FI952612L (en) Oxalylaminobenzofuran and benzothienyl derivatives
DE69735712D1 (en) ARYL-PYRIMIDINE DERIVATIVES
ATE261942T1 (en) 6-PHENYLPYRIDINE DERIVATIVES
HU9701193D0 (en) N-(4-aryl-thiazol-2-yl)-sulfonamide derivatives and their use
DK0906301T3 (en) Benzofuryl derivatives and their use
FI952424L (en) 11,21-bisphenyl-19-norpregane derivatives
DK0721457T3 (en) 2 ', 5'-oligoadenylate-2', 3'-cyclophosphates and 2 ', 5'-oligo-adenylates with antipapillomavirus activity
IS5942A (en) 3,3-barylpiperidine and 2,2-barylmorpholine derivatives
NO983100D0 (en) 4,5-dihydronaphth £ 1,2-Cisoxazoles and derivatives thereof with CNS activity
PT811593E (en) INSECTICID AND ACARICID AGENTS 1,4-DIARY-2-FLUOR-2-BUTENE
NO992542D0 (en) Class D amplifier
NO984921D0 (en) Tienopyridine derivatives and their use
ATE240941T1 (en) 1,25-DIHYDROXY-16,22,23-TRISDEHYDRO-CHOLECALCIFEROL DERIVATIVES
DE59701830D1 (en) Fastener pair
DE69711853D1 (en) Pyridinecarboxamide DERIVATIVES
BR9508669A (en) New derivatives of taizoloÚ3,2-a¾quinoline and naphthyrine
NO991123D0 (en) 25-methylene and 24,25-epoxy-marcfortins and parahercamides
DE69416307D1 (en) SWING
KR950008231U (en) Swing
DK0906297T3 (en) 1,2,4-Benzothiadiazine derivatives, preparation and use thereof
KR970060531U (en) Swing bed
KR970049130U (en) Swing

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application